Pilot Study of Bisphosphonates for Breast Cancer

NCT02781805 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Alendronate

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]